COVID‐19 mortality in cirrhosis is determined by cirrhosis‐associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry

BACKGROUND AND OBJECTIVE: International registries have reported high mortality rates in patients with liver disease and COVID‐19. However, the extent to which comorbidities contribute to excess COVID‐19 mortality in cirrhosis is controversial. METHODS: We used the multinational Lean European Open S...

Descripción completa

Detalles Bibliográficos
Autores principales: Brozat, Jonathan F., Hanses, Frank, Haelberger, Martina, Stecher, Melanie, Dreher, Michael, Tometten, Lukas, Ruethrich, Maria M., Vehreschild, Janne J., Trautwein, Christian, Borgmann, Stefan, Vehreschild, Maria J. G. T., Jakob, Carolin E. M., Stallmach, Andreas, Wille, Kai, Hellwig, Kerstin, Isberner, Nora, Reuken, Philipp A., Geisler, Fabian, Nattermann, Jacob, Bruns, Tony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Hepatobiliary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103364/
https://www.ncbi.nlm.nih.gov/pubmed/35482663
http://dx.doi.org/10.1002/ueg2.12232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103364/
https://www.ncbi.nlm.nih.gov/pubmed/35482663
http://dx.doi.org/10.1002/ueg2.12232

Ejemplares similares